D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
LyondellBasell Industries
LYB
$19B
| $12.9M | 0.01% |
+124,088
| New | +$12.3M |
|
1102
CALL
Credit Acceptance
CACC
$5.82B
| $12.9M | 0.01% |
35,800
+25,900
| +262% | +$9.39M |
|
1103
Choice Hotels
CHH
$5.16B
| $12.9M | 0.01% |
119,916
+83,816
| +232% | +$8.93M |
|
|
CTRA
1104
DELISTED
Coterra Energy
CTRA
| $12.9M | 0.01% |
684,894
+122,060
| +22% | +$2.25M |
|
1105
ManpowerGroup
MAN
$2.48B
| $12.8M | 0.01% |
129,887
+34,773
| +37% | +$3.33M |
|
1106
Syndax Pharmaceuticals
SNDX
$1.84B
| $12.8M | 0.01% |
573,938
-81,069
| -12% | -$1.83M |
|
1107
Toro Company
TTC
$9.02B
| $12.8M | 0.01% |
124,384
-4,843
| -4% | -$484K |
|
|
SPWR
1108
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $12.8M | 0.01% |
383,200
+363,200
| +1,816% | +$13.6M |
|
|
ABMD
1109
CALL
DELISTED
Abiomed Inc
ABMD
| $12.8M | 0.01% |
40,200
-4,500
| -10% | -$1.44M |
|
|
HMSY
1110
DELISTED
HMS Holdings Corp.
HMSY
| $12.8M | 0.01% |
346,028
-279,746
| -45% | -$10.3M |
|
|
CYBR
1111
PUT
DELISTED
CyberArk
CYBR
| $12.8M | 0.01% |
98,700
+10,000
| +11% | +$1.51M |
|
1112
CALL
Pfizer
PFE
$141B
| $12.8M | 0.01% |
352,000
-103,000
| -23% | -$3.66M |
|
1113
Healthpeak Properties
DOC
$15.5B
| $12.7M | 0.01% |
401,367
-53,668
| -12% | -$1.63M |
|
1114
Fastenal
FAST
$54.7B
| $12.7M | 0.01% |
505,954
-1,254,494
| -71% | -$30M |
|
1115
Celestica
CLS
$36.5B
| $12.7M | 0.01% |
1,515,410
+136,770
| +10% | +$1.17M |
|
1116
CALL
Costco
COST
$422B
| $12.7M | 0.01% |
35,900
-23,000
| -39% | -$8.01M |
|
|
Y
1117
PUT
DELISTED
Alleghany Corp
Y
| $12.7M | 0.01% |
20,200
-10,000
| -33% | -$6.19M |
|
1118
Herbalife
HLF
$1.27B
| $12.6M | 0.01% |
284,825
-1,287,062
| -82% | -$63.5M |
|
1119
Service Corp International
SCI
$11.5B
| $12.6M | 0.01% |
246,825
-69,163
| -22% | -$3.46M |
|
1120
Manitowoc
MTW
$528M
| $12.6M | 0.01% |
608,961
+12,414
| +2% | +$205K |
|
1121
Innoviva
INVA
$1.58B
| $12.5M | 0.01% |
1,049,398
-95,123
| -8% | -$1.15M |
|
|
1122
CALL
Baidu
BIDU
$35.8B
| $12.5M | 0.01% |
57,500
-119,200
| -67% | -$31.1M |
|
1123
CALL
Ally Financial
ALLY
$13.3B
| $12.5M | 0.01% |
275,900
+202,000
| +273% | +$8.45M |
|
1124
PUT
SLB Ltd
SLB
$76.5B
| $12.4M | 0.01% |
457,800
-464,000
| -50% | -$12.2M |
|
1125
Axogen
AXGN
$2.19B
| $12.4M | 0.01% |
612,632
-44,114
| -7% | -$871K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.